Form 4/A for UTHR UNITED THERAPEUTICS Corp
Accepted 2022-03-04 00:00:00 ET · period of report 2022-01-06 · accession 0001127602-22-008274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2022-03-04 | 2022-01-06 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $192.46 | -6,000 | 42.0K | -12% | -$1.15M |
| DA | 2022-03-04 | 2022-01-06 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DA | 2022-03-04 | 2022-01-06 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 1,094 | -85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | S | D | 2,710 | $192.85 | 36,369 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $192.65 to $193.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-01-06 | S | D | 2,970 | $192.32 | 39,079 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $191.65 to $192.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-01-06 | S | D | 320 | $190.48 | 42,049 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $190.32 to $190.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2022-01-06 | M | A | 6,000 | $111.00 | 42,369 | D | — | — | |
| 5 | Derivative | Stock Options | 2022-01-06 | M | D | 6,000 | $0.00 | 1,094 | D | $111.00 · 2019-03-15 to 2028-03-15 | 6,000 Common Stock | (F6) The reporting person received two stock option grants, both with the same grant date and exercise price. Due to administrative error, previous option exercises occasionally were reported on Table II as having been drawn from the wrong tranche. This balance has been updated to correct these errors. |